Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular surgery.
Who is the study for?
This trial is for children who need heart surgery and will have their chest bone cut (sternotomy). It's to see if REPEL-CV can prevent tissues from sticking together after the operation. Kids can't join if they're planning to close up the chest more than 5 days after surgery.Check my eligibility
What is being tested?
The study is testing REPEL-CV, a product designed to reduce tissue adhesions that can occur after heart surgeries in kids. The focus is on its effectiveness when used during initial sternotomies.See study design
What are the potential side effects?
While specific side effects of REPEL-CV are not detailed here, generally such products may cause irritation at the site of application or an allergic reaction.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
SyntheMedLead Sponsor
Eli PinesStudy DirectorSyntheMed
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a sternotomy.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this methodology known to be secure for patients?
"This treatment's safety rating is 2 due to the fact that, although there are some data points regarding its safety, it lacks any efficacy-related clinical evidence."
Answered by AI
Is this clinical experiment open to participants aged under 75 years?
"In order to be eligible for this trial, applicants must fall within the age range of 1 Day and 1 Year. Alternatively, 4 medical trials are available for those younger than 18 years old and a dozen clinical studies can be accessed by seniors over 65."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger